フェリチン検査の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

フェリチン検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のフェリチン検査市場規模は2025～2030年にかけてCAGR 8.0％を記録し、2030年には14億6,000万米ドルに達すると予測されています。

同市場は、鉄欠乏性貧血の世界の蔓延により大きく成長しています。世界保健機関（WHO）によると、貧血は19億人以上が罹患しており、鉄欠乏が主要原因となっています。特に女性、幼児、高齢者におけるこの負担の増大が、鉄レベルをモニターするためのフェリチン検査の需要を促進しています。例えばインドでは、Anemia Mukt Bharatキャンペーンのような政府のイニシアチブが貧血早期診断の重要性を強調し、フェリチン検査の採用を後押ししています。

診断における技術革新は市場の主要促進要因です。自動検査システムやポイントオブケア（POC）機器により、フェリチンの測定がより迅速かつ正確に行えるようになっています。RocheやAbbottのような企業は、最小限のサンプル量で正確な結果が得られる、免疫測定法をベースとした先進的なシステムを発表しています。例えば、ロシュのElecsysフェリチン検査は、効率的な貧血管理、ワークフローの合理化、納期短縮のために、病院や診断ラボで広く使用されています。

早期診断と予防医療の重要性に対する意識の高まりが、フェリチン検査の需要を促進しています。欧州や北米のような地域では、教育キャンペーンや公衆衛生の取り組みにより、特に妊婦や幼児のようなリスクのあるグループに対して、鉄欠乏症の定期的なスクリーニングが奨励されています。米国では、疾病対策予防センター（CDC）が乳幼児や出産適齢期の女性に対する定期的な貧血スクリーニングを推奨しており、市場の安定成長に寄与しています。アジア太平洋、ラテンアメリカ、アフリカの新興国は、医療インフラの改善と診断サービスへのアクセス向上により、急速な市場成長を遂げています。例えば中国では、政府が母子の健康に重点を置いているため、出生前の定期検診にフェリチン検査が広く採用されています。同様にブラジルでは、SUS（Sistema Unico de Saude）のような公的プログラムによる医療アクセスの拡大が、貧血診断のためのフェリチン検査の使用を後押ししています。

Abbott、Siemens Healthineers、bioMerieuxなどの主要企業が市場の成長を牽引しています。これらの企業は革新的な検査ソリューションを導入するために研究開発に投資しています。例えば、Siemens Healthineersは、病院の検査室にシームレスに統合できるAtellica Solutionプラットフォームと互換性のある先進的なフェリチン測定法を提供しています。加えて、貧血スクリーニング・プログラムにおける提携など、診断企業と政府間の協力関係も市場をさらに拡大しています。同市場の主要参入企業としては、BioMrieux、Humankind Ventures Ltd、Aviva Systems Biology Corporation、Abnova Corporation、Randox Laboratories Ltdなどが挙げられます。これらの企業は、世界の顧客に対応するため、製品の発売や承認など、さまざまな戦略的取り組みを行っています。

フェリチン検査市場レポートハイライト

• 製品別では、試薬が2024年に45.27%の最大収益シェアを占めました。同市場は、ELISAや化学発光免疫測定法のようなイムノアッセイベースの診断技術の採用が拡大しており、正確で高感度なフェリチン測定のために高品質の試薬に依存しています。例えば、試薬製剤にモノクローナル抗体を使用することで、検査の特異性と信頼性が向上しています。Thermo Fisher Scientificやロシュ・ダイアグノスティックスなどの市場開拓企業は、自動化プラットフォームに最適化された試薬を開発することで技術革新を推進し、市場拡大をさらに加速させています。さらに、試薬の定期的な需要により、特に大規模な診断ラボや病院では安定した収益が確保されています。
• 用途別では、貧血が市場を独占し、2024年には41.47%の最大シェアを占めました。貧血は世界人口の4分の1に影響を及ぼしており、女性、妊産婦、少女、5歳以下の幼児の間でますます一般的になっています。2021年までに、推定19億2,000万人が貧血とともに生活しており、過去30年間で4億2,000万件増加しています。この急増は、特に開発途上地域における栄養不良、慢性疾患、限られた医療アクセスなどの要因によるものです。貧血の診断と治療に対する需要の高まりが市場成長の原動力となっています。さらに、世界の検査市場の拡大、特にポイントオブケアや家庭用検査機器の拡大が、貧血の検出と管理によりアクセスしやすいソリューションを提供し、この成長を後押しすると予想されます。
• 最終用途別では、病院が2024年に56.32%の最大市場シェアを占めています。市場成長の原動力は、患者数の増加、医療技術の進歩、専門的治療に対する需要の高まりなどの要因です。また、特に新興国における医療インフラの拡充が、この成長を促進する上で重要な役割を果たしています。病院は、患者の転帰を向上させ、業務効率を最適化するために、迅速検査装置を含む先進的診断ツールの導入を進めています。こうした開発により、医療セグメントでは革新的なソリューションに対する旺盛な需要が生まれている
• 北米は、主に鉄欠乏性貧血とその関連疾患の有病率の増加により、世界市場を独占しています。鉄欠乏性貧血の早期診断とモニタリングの重要性に対する認識が高まっていることが、この動向に拍車をかけています。人口の高齢化と、鉄代謝に影響を与える腎臓病やがんなどの慢性疾患の罹患率の上昇も、フェリチン検査の需要を押し上げています。さらに、ポイントオブケア検査やラボベースのソリューションを含む診断技術の進歩は、アクセシビリティと効率性を向上させ、同地域での市場拡大に寄与しています。
• アジア太平洋は、診断研究能力の加速と相まって革新的な機器を持つメーカーの存在により、2025～2030年までの予測期間でCAGR 9.23%と最も速い成長が見込まれています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場セグメンテーションと範囲
• 市場系統の展望
  • 親市場の展望
  • 関連/補助市場展望
• 市場動向と展望
• 市場力学
• 市場抑制要因分析
• ビジネス環境分析
  • SWOT分析、要因別（政治・法律、経済技術）
  • ポーターのファイブフォース分析

第4章 製品ビジネス分析

• フェリチン検査市場：製品変動分析
• 機器
  • 機器市場、2018～2030年
• 試薬
  • 試薬市場、2018～2030年
• キット
  • キット市場、2018～2030年

第5章 用途ビジネス分析

• フェリチン検査市場：用途変動分析
• 貧血
  • 貧血市場、2018～2030年
• ヘモクロマトーシス
  • ヘモクロマトーシス市場、2018～2030年
• 鉛中毒
  • 鉛中毒市場、2018～2030年
• 妊娠
  • 妊娠市場、2018～2030年
• その他
  • その他市場、2018～2030年

第6章 最終用途ビジネス分析

• フェリチン検査市場：最終用途変動分析
• 病院
  • 病院市場、2018～2030年
• 診断ラボ
  • 診断ラボユニット市場、2018～2030年

第7章 地域ビジネス分析

• フェリチン検査市場シェア（地域別）、2024年と2030年
• 北米
  • 北米フェリチン検査市場、2018～2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州のフェリチン検査市場、2018～2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋のフェリチン検査市場、2018～2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカのフェリチン検査市場、2018～2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカのフェリチン検査市場、2018～2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業分類
• 戦略マッピング
• 企業市場シェア分析、2024年
• 企業プロファイル/上場企業
  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc
  • Pointe Scientific, Inc
  • Humankind Ventures Ltd
  • Aviva Systems Biology Corporation
  • bioMerieux SA
  • Abnova Corporation
  • Cosmic Scientific Technologies
  • CTK BIoTech, Inc
  • Thermo Fisher Scientific Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 5 Global ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 6 North America ferritin testing market, by Country, 2018 - 2030 (USD Million)
• Table 7 North America ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 8 North America ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 9 North America ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 10 U.S. ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 11 U.S. ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 12 U.S. ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 13 Canada ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 14 Canada ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 15 Canada ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 16 Mexico ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 17 Mexico ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 18 Mexico ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 19 Europe ferritin testing market, by Country, 2018 - 2030 (USD Million)
• Table 20 Europe ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 21 Europe ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 22 Europe ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 23 Germany ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 24 Germany ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 25 Germany ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 26 UK ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 27 UK ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 28 UK ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 29 France ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 30 France ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 31 France ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 32 Italy ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 33 Italy ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 34 Italy ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 35 Spain ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 36 Spain ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 37 Spain ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 38 Denmark ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 39 Denmark ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 40 Denmark ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 41 Sweden ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 42 Sweden ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 43 Sweden ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 44 Norway ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 45 Norway ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 46 Norway ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific ferritin testing market, by Country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 51 China ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 52 China ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 53 China ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 54 Japan ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 55 Japan ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 56 Japan ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 57 India ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 58 India ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 59 India ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 60 South Korea ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 61 South Korea ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 62 South Korea ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 63 Australia ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 64 Australia ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 65 Australia ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 66 Thailand ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 67 Thailand ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 68 Thailand ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 69 Latin America ferritin testing market, by Country, 2018 - 2030 (USD Million)
• Table 70 Latin America ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 71 Latin America ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 72 Latin America ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 73 Brazil ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 74 Brazil ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 75 Brazil ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 76 Argentina ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 77 Argentina ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 78 Argentina ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa ferritin testing market, by Country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 83 South Africa ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 84 South Africa ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 85 South Africa ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 89 UAE ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 90 UAE ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 91 UAE ferritin testing market, by End Use, 2018 - 2030 (USD Million)
• Table 92 Kuwait ferritin testing market, by Product, 2018 - 2030 (USD Million)
• Table 93 Kuwait ferritin testing market, by Application, 2018 - 2030 (USD Million)
• Table 94 Kuwait ferritin testing market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Ferritin Testing Market Segmentation
• Fig. 8 Market Snapshot, 2024
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Global Ferritin Testing Market, Product Movement Analysis
• Fig. 16 Global Ferritin Testing Market, for Instrument, 2018 - 2030 (USD Million)
• Fig. 17 Global Ferritin Testing Market, for Reagent, 2018 - 2030 (USD Million)
• Fig. 18 Global Ferritin Testing Market, for Kits, 2018 - 2030 (USD Million)
• Fig. 19 Global Ferritin Testing Market, Application Movement Analysis
• Fig. 20 Global Ferritin Testing Market, for Anemia, 2018 - 2030 (USD Million)
• Fig. 21 Global Ferritin Testing Market, for Hemochromatosis, 2018 - 2030 (USD Million)
• Fig. 22 Global Ferritin Testing Market, for Lead Poisoning, 2018 - 2030 (USD Million)
• Fig. 23 Global Ferritin Testing Market, for Pregnancy, 2018 - 2030 (USD Million)
• Fig. 24 Global Ferritin Testing Market, for Others, 2018 - 2030 (USD Million)
• Fig. 25 Global Ferritin Testing Market, End-use Movement Analysis
• Fig. 26 Global Ferritin Testing Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 27 Global Ferritin Testing Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
• Fig. 28 Regional Marketplace: Key Takeaways
• Fig. 29 Regional Outlook, 2024 & 2030
• Fig. 30 Global Ferritin Testing Market, Region Movement Analysis
• Fig. 31 North America Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 32 U.S. Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 33 Canada Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 34 Mexico Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 35 Europe Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 36 Germany Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 37 UK Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 38 France Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 39 Italy Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 40 Spain Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 41 Denmark Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 42 Sweden Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 43 Norway Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 45 Japan Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 46 China Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 47 India Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 48 Australia Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 49 South Korea Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 50 Thailand Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 51 Latin America Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 52 Brazil Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 55 South Africa Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 57 UAE Ferritin Testing Market, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Ferritin Testing Market, 2018 - 2030 (USD Million)

Ferritin Testing Market Growth & Trends:

The global ferritin testing market size is expected to reach USD 1.46 billion by 2030, registering a CAGR of 8.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is growing significantly due to the global prevalence of iron deficiency anemia. According to the World Health Organization (WHO), anemia affects over 1.9 billion people, with iron deficiency being a leading cause. This growing burden, particularly among women, children, and the elderly, is driving the demand for ferritin tests to monitor iron levels. For instance, in India, government initiatives like the Anemia Mukt Bharat campaign emphasize the importance of early anemia diagnosis, boosting the adoption of ferritin testing.

Technological innovations in diagnostics are a key driver of the market. Automated laboratory systems and point-of-care (POC) devices are enabling faster and more accurate ferritin measurements. Companies like Roche and Abbott have introduced advanced immunoassay-based systems that provide precise results with minimal sample volume. For instance, Roche's Elecsys ferritin test is widely used in hospitals and diagnostic labs for efficient anemia management, streamlining workflows, and reducing turnaround times.

Rising awareness of the importance of early diagnosis and preventive healthcare fuels the demand for ferritin testing. Educational campaigns and public health initiatives in regions like Europe and North America encourage routine screening for iron deficiency, particularly for at-risk groups such as pregnant women and children. In the U.S., the Centers for Disease Control and Prevention (CDC) recommend regular anemia screenings for infants and women of childbearing age, contributing to the steady market growth. Emerging economies in Asia Pacific, Latin America, and Africa are witnessing rapid market growth due to improved healthcare infrastructure and increased access to diagnostic services. For example, in China, the government's focus on maternal and child health has led to the widespread adoption of ferritin tests in routine prenatal checkups. Similarly, in Brazil, expanding healthcare access through public programs like SUS (Sistema Unico de Saude) has boosted the use of ferritin tests for anemia diagnosis.

Leading companies in the market, such as Abbott, Siemens Healthineers, and bioMerieux, are pivotal in driving growth. These players are investing in research and development to introduce innovative testing solutions. For example, Siemens Healthineers offers advanced ferritin assays compatible with their Atellica Solution platforms, which integrate seamlessly into hospital laboratories. In addition, collaborations between diagnostic companies and governments, such as partnerships for anemia screening programs, are further expanding the market's reach. Some of the key players in the market are BioMrieux, Humankind Ventures Ltd, Aviva Systems Biology Corporation, Abnova Corporation, and Randox Laboratories Ltd. These players are involved in various strategic initiatives, such as product launches and approvals, to cater to a global clientele.

Ferritin Testing Market Report Highlights:

• Based on product, reagent accounted for the largest revenue share of 45.27% in 2024. The market is being propelled by the growing adoption of immunoassay-based diagnostic techniques like ELISA and chemiluminescent immunoassays, which depend on high-quality reagents for precise and sensitive ferritin measurement. For example, the increasing use of monoclonal antibodies in reagent formulations enhances the specificity and reliability of tests. Companies such as Thermo Fisher Scientific and Roche Diagnostics are driving innovation by developing reagents optimized for automated platforms, further accelerating market expansion. Moreover, the recurring demand for reagents ensures steady revenue, particularly in large diagnostic laboratories and hospitals
• Based on application, anemia dominated the market and accounted for the largest share of 41.47% in 2024. Anemia, affecting one-fourth of the global population, is becoming increasingly common among women, expectant mothers, young girls, and children under 5. By 2021, an estimated 1.92 billion people were living with anemia, a rise of 420 million cases over the last 30 years. This surge is attributed to factors like poor nutrition, chronic illnesses, and limited healthcare access, particularly in developing regions. The growing demand for anemia diagnostics and treatments is driving market growth. Furthermore, the expansion of the global testing market, especially in point-of-care and home-testing devices, is expected to boost this growth, offering more accessible solutions for anemia detection and management
• Based on end use, hospitals dominated end use with the largest market share of 56.32% in 2024. The market growth is fueled by factors such as increasing patient volumes, advancements in medical technology, and the rising demand for specialized treatments. In addition, the expansion of healthcare infrastructure, particularly in emerging economies, plays a significant role in driving this growth. Hospitals are progressively adopting advanced diagnostic tools, including rapid testing devices, to enhance patient outcomes and optimize operational efficiency. These developments are creating a robust demand for innovative solutions in the healthcare sector
• North America dominated the global market, primarily due to the increasing prevalence of iron deficiency anemia and related conditions. Greater awareness of the importance of early diagnosis and monitoring of iron levels is fueling this trend. The aging population and the rising incidence of chronic diseases, such as kidney disease and cancer, which impact iron metabolism, are also driving demand for ferritin tests. Furthermore, advancements in diagnostic technologies, including point-of-care testing and lab-based solutions, are improving accessibility and efficiency, contributing to the market's expansion in the region.
• The Asia Pacific region is expected to witness the fastest growth with a CAGR of 9.23% over the forecast period from 2025 to 2030 due to the presence of manufacturers with innovative devices coupled with accelerated diagnostic research capabilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model
  • 1.4.1. Market Study, By Company Market Share
  • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
• 3.5. Market Restraint Analysis
• 3.6. Business Environment Analysis
  • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Product Business Analysis

• 4.1. Ferritin Testing Market: Product Movement Analysis
• 4.2. Instrument
  • 4.2.1. Instrument Market, 2018 - 2030 (USD Million)
• 4.3. Reagent
  • 4.3.1. Reagent Market, 2018 - 2030 (USD Million)
• 4.4. Kits
  • 4.4.1. Kits Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

• 5.1. Ferritin Testing Market: Application Movement Analysis
• 5.2. Anemia
  • 5.2.1. Anemia Market, 2018 - 2030 (USD Million)
• 5.3. Hemochromatosis
  • 5.3.1. Hemochromatosis Market, 2018 - 2030 (USD Million)
• 5.4. Lead Poisoning
  • 5.4.1. Lead Poisoning Market, 2018 - 2030 (USD Million)
• 5.5. Pregnancy
  • 5.5.1. Pregnancy Market, 2018 - 2030 (USD Million)
• 5.6. Others
  • 5.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End Use Business Analysis

• 6.1. Ferritin Testing Market: End Use Movement Analysis
• 6.2. Hospitals
  • 6.2.1. Hospitals Market, 2018 - 2030 (USD Million)
• 6.3. Diagnostic Laboratories
  • 6.3.1. Diagnostic Laboratories Unit Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

• 7.1. Ferritin Testing Market Share By Region, 2024 & 2030
• 7.2. North America
  • 7.2.1. North America Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. Key Country Dynamics
    • 7.2.2.2. Target Disease Prevalence
    • 7.2.2.3. Competitive Scenario
    • 7.2.2.4. Regulatory Framework
    • 7.2.2.5. Reimbursement Scenario
    • 7.2.2.6. U.S. Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Key Country Dynamics
    • 7.2.3.2. Target Disease Prevalence
    • 7.2.3.3. Competitive Scenario
    • 7.2.3.4. Regulatory Framework
    • 7.2.3.5. Reimbursement Scenario
    • 7.2.3.6. Canada Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Key Country Dynamics
    • 7.2.4.2. Target Disease Prevalence
    • 7.2.4.3. Competitive Scenario
    • 7.2.4.4. Regulatory Framework
    • 7.2.4.5. Reimbursement Scenario
    • 7.2.4.6. Mexico Ferritin Testing Market, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.2. Germany
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Target Disease Prevalence
    • 7.3.2.3. Competitive Scenario
    • 7.3.2.4. Regulatory Framework
    • 7.3.2.5. Reimbursement Scenario
    • 7.3.2.6. Germany Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.3. UK
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Target Disease Prevalence
    • 7.3.3.3. Competitive Scenario
    • 7.3.3.4. Regulatory Framework
    • 7.3.3.5. Reimbursement Scenario
    • 7.3.3.6. UK Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Target Disease Prevalence
    • 7.3.4.3. Competitive Scenario
    • 7.3.4.4. Regulatory Framework
    • 7.3.4.5. Reimbursement Scenario
    • 7.3.4.6. France Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Key Country Dynamics
    • 7.3.5.2. Target Disease Prevalence
    • 7.3.5.3. Competitive Scenario
    • 7.3.5.4. Regulatory Framework
    • 7.3.5.5. Reimbursement Scenario
    • 7.3.5.6. Italy Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Key Country Dynamics
    • 7.3.6.2. Target Disease Prevalence
    • 7.3.6.3. Competitive Scenario
    • 7.3.6.4. Regulatory Framework
    • 7.3.6.5. Reimbursement Scenario
    • 7.3.6.6. Spain Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Key Country Dynamics
    • 7.3.7.2. Target Disease Prevalence
    • 7.3.7.3. Competitive Scenario
    • 7.3.7.4. Regulatory Framework
    • 7.3.7.5. Reimbursement Scenario
    • 7.3.7.6. Denmark Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.8. Sweden
    • 7.3.8.1. Key Country Dynamics
    • 7.3.8.2. Target Disease Prevalence
    • 7.3.8.3. Competitive Scenario
    • 7.3.8.4. Regulatory Framework
    • 7.3.8.5. Reimbursement Scenario
    • 7.3.8.6. Sweden Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.3.9. Norway
    • 7.3.9.1. Key Country Dynamics
    • 7.3.9.2. Target Disease Prevalence
    • 7.3.9.3. Competitive Scenario
    • 7.3.9.4. Regulatory Framework
    • 7.3.9.5. Reimbursement Scenario
    • 7.3.9.6. Norway Ferritin Testing Market, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.4.2. Japan
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Target Disease Prevalence
    • 7.4.2.3. Competitive Scenario
    • 7.4.2.4. Regulatory Framework
    • 7.4.2.5. Reimbursement Scenario
    • 7.4.2.6. Japan Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.4.3. China
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Target Disease Prevalence
    • 7.4.3.3. Competitive Scenario
    • 7.4.3.4. Regulatory Framework
    • 7.4.3.5. Reimbursement Scenario
    • 7.4.3.6. China Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Target Disease Prevalence
    • 7.4.4.3. Competitive Scenario
    • 7.4.4.4. Regulatory Framework
    • 7.4.4.5. Reimbursement Scenario
    • 7.4.4.6. India Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Target Disease Prevalence
    • 7.4.5.3. Competitive Scenario
    • 7.4.5.4. Regulatory Framework
    • 7.4.5.5. Reimbursement Scenario
    • 7.4.5.6. South Korea Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Target Disease Prevalence
    • 7.4.6.3. Competitive Scenario
    • 7.4.6.4. Regulatory Framework
    • 7.4.6.5. Reimbursement Scenario
    • 7.4.6.6. Australia Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Target Disease Prevalence
    • 7.4.7.3. Competitive Scenario
    • 7.4.7.4. Regulatory Framework
    • 7.4.7.5. Reimbursement Scenario
    • 7.4.7.6. Thailand Ferritin Testing Market, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Target Disease Prevalence
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. Regulatory Framework
    • 7.5.2.5. Reimbursement Scenario
    • 7.5.2.6. Brazil Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Target Disease Prevalence
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Regulatory Framework
    • 7.5.3.5. Reimbursement Scenario
    • 7.5.3.6. Argentina Ferritin Testing Market, 2018 - 2030 (USD Million)
• 7.6. MEA
  • 7.6.1. MEA Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.6.2. South Africa
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Target Disease Prevalence
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. Regulatory Framework
    • 7.6.2.5. Reimbursement Scenario
    • 7.6.2.6. South Africa Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.6.3. Saudi Arabia
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Target Disease Prevalence
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Regulatory Framework
    • 7.6.3.5. Reimbursement Scenario
    • 7.6.3.6. Saudi Arabia Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.6.4. UAE
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Target Disease Prevalence
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. Regulatory Framework
    • 7.6.4.5. Reimbursement Scenario
    • 7.6.4.6. UAE Ferritin Testing Market, 2018 - 2030 (USD Million)
  • 7.6.5. Kuwait
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Target Disease Prevalence
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Regulatory Framework
    • 7.6.5.5. Reimbursement Scenario
    • 7.6.5.6. Kuwait Ferritin Testing Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Share Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Eurolyser Diagnostica GmbH
    • 8.4.1.1. Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Collection Site Benchmarking
    • 8.4.1.4. Strategic Initiatives
  • 8.4.2. Cortez Diagnostics Inc
    • 8.4.2.1. Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Collection Site Benchmarking
    • 8.4.2.4. Strategic Initiatives
  • 8.4.3. Pointe Scientific, Inc
    • 8.4.3.1. Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Collection Site Benchmarking
    • 8.4.3.4. Strategic Initiatives
  • 8.4.4. Humankind Ventures Ltd
    • 8.4.4.1. Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Collection Site Benchmarking
    • 8.4.4.4. Strategic Initiatives
  • 8.4.5. Aviva Systems Biology Corporation
    • 8.4.5.1. Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Collection Site Benchmarking
    • 8.4.5.4. Strategic Initiatives
  • 8.4.6. bioMerieux S.A
    • 8.4.6.1. Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Collection Site Benchmarking
    • 8.4.6.4. Strategic Initiatives
  • 8.4.7. Abnova Corporation
    • 8.4.7.1. Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Collection Site Benchmarking
    • 8.4.7.4. Strategic Initiatives
  • 8.4.8. Cosmic Scientific Technologies
    • 8.4.8.1. Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Collection Site Benchmarking
    • 8.4.8.4. Strategic Initiatives
  • 8.4.9. CTK Biotech, Inc
    • 8.4.9.1. Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Collection Site Benchmarking
    • 8.4.9.4. Strategic Initiatives
  • 8.4.10. Thermo Fisher Scientific Inc.
    • 8.4.10.1. Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Collection Site Benchmarking
    • 8.4.10.4. Strategic Initiatives